Homozygosity for a factor XII mutation in one female and one male patient with hereditary angio-oedema.

Grumach, A S; Stieber, C; Veronez, C L; Cagini, N; Constantino-Silva, R N; Cordeiro, E; Nöthen, M M; Pesquero, J B et al. · Allergy · 2016

case_report · Level V

Where this comes from

Abstract

Hereditary angio-oedema (HAE) with normal C1 inhibitor is associated with heterozygous mutations in the factor XII gene (FXII-HAE). We report two Brazilian FXII-HAE families segregating the mutation c.983 C>A (p.Thr328Lys). In each family, one patient with a homozygous mutation was found. The homozygous female patient in family 1 displayed a severe phenotype. However, this falls within the clinical phenotype spectrum reported for heterozygous female mutation carriers. The homozygous male patient in family 2 also showed a severe phenotype. This finding is intriguing, as to our knowledge, it is the first such report for a male FXII-HAE mutation carrier. In the rare instances in which male mutation carriers are affected, a mild phenotype is typical. The present findings therefore suggest that homozygous FXII-HAE mutation status leads to a severe phenotype in females and males, and to an increased risk of manifest symptoms in the latter.

Medical subject headings